MedPath
EMA Product

Pylobactell

Product approved by European Medicines Agency (EU)

Basic Information

Pylobactell

Regulatory Information

EMEA/H/C/000151

Authorised

May 7, 1998

12

December 4, 2023

Company Information

Italy

Via San Cristoforo 78 20090 Trezzano Sul Naviglio (Ml)

Richen Europe S.r.l.

Active Substances Detail

Detailed Information

Therapeutic Indication

### Therapeutic indication This medicinal product is for diagnostic use only. For in vivo diagnosis of gastroduodenal Helicobacter pylori (H. pylori) infection.

Overview Summary

This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach its recommendations on how to use the medicine. If you need more information about your medical condition or your treatment, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis of the CHMP recommendations, read the scientific discussion (also part of the EPAR).

© Copyright 2025. All Rights Reserved by MedPath